The genes are PDGFRB, ABL1, FLT1; and these genes are drug targets of cancer drugs like Dasatinib (targets – PDGFRB, ABL1), Pazopanib (targets – PDGFRB, FLT1), Ponatinib (target – ABL1)26. The gene discussed is FLT1; the disease is cancer.